Management Forum Logo

Presented by
Management Forum

Mastering US Patent Practice: Prosecution, Strategy and Recent Developments Training Course

What all European patent attorneys need to know - an intensive and highly interactive training course that includes discussions on US patent law and strategies and tactics for patent prosecution at the US Patent Office

★★★★★ "Great course materials with plenty of detail which I can use in the future."

3-6 November 2026 »
from £1199

Need help?  Enrol/reserve

Course overview

The United States remains one of the world's most important and commercially significant patent jurisdictions. However, US patent law continues to evolve rapidly, creating challenges for patent attorneys, in-house counsel and IP professionals responsible for protecting innovation globally.

This comprehensive and highly practical training course provides a detailed understanding of modern US patent practice, prosecution strategy and enforcement. Delegates will gain valuable insight into the latest developments at the USPTO, key Federal Circuit and Supreme Court decisions, and emerging trends affecting patentability, claim drafting, prosecution and post-grant proceedings.

The course will explain the critical differences between US and European patent practice and provide practical guidance on drafting and prosecuting stronger US patent applications. Particular attention will be given to subject matter eligibility, enablement, written description requirements, restriction practice, continuation practice, PTAB proceedings and recent developments impacting software, AI and technology-based inventions.

Attendees will learn how to navigate the US patent system more effectively, maximise patent value, reduce prosecution risk and work more efficiently with US counsel and inventors.

Key topics covered:

  • Legal framework
  • Claim construction and drafting
  • US patent prosecution practice and procedure
  • Written description and enablement
  • Alice and its continuing impact on subject matter eligibility
  • Software
  • AI-assisted inventions
  • Novelty and prior art
  • Obviousness
  • Functional claiming
  • Method claims
  • Provisional and continuing applications
  • Restriction practice
  • Current PTAB trends
  • Inventorship and ownership
  • Direct and indirect infringement
  • Licensing considerations
  • Emerging USPTO initiatives
  • International developments impacting US practice
     

Through practical examples, case studies and interactive discussions, delegates will gain the knowledge and confidence needed to develop effective US patent strategies in an increasingly complex legal environment.

This training course will also give you the opportunity to ask questions and discuss your real-life challenges with the expert trainer. 

This course is part of our collection of IP & Patents Training Courses.

Benefits of attending

This is a fantastic opportunity to take full advantage of the open training course environment that this programme offers. With a high degree of interaction with the expert trainer, as well as other participants, this is a great forum for discussing your particular questions and challenges.

Offering a wide-ranging and detailed understanding, this training course covers what every European patent practitioner should know about US patent practice.

By attending this training course you will:

  • Gain a practical understanding of modern US patent prosecution practice
  • Understand the key differences between US and European patent systems
  • Learn how recent USPTO guidance and court decisions affect patentability
  • Explore current approaches to software, AI and computer-implemented inventions
  • Improve patent drafting strategies for US prosecution and enforcement
  • Build knowledge on continuation, divisional and provisional application strategies
  • Develop practical approaches to overcoming novelty and obviousness objections
  • Identify how PTAB proceedings can impact patent portfolios
  • Evaluate recent developments in patent term adjustment and terminal disclaimers
  • Explore infringement, enforcement and litigation considerations
  • Stay up to date with current USPTO initiatives and examination trends
  • Gain practical insight into managing US patent portfolios more effectively

Who should attend?

This training course has been specially designed for:

  • Corporate patent counsel
  • Patent attorneys from in-house and private practice
  • European patent lawyers
  • UK patent lawyers
  • US patent attorneys
  • Patent managers
  • Patent engineers
  • IP directors
  • Technology transfer professionals
  • Intellectual property consultants
  • R&D managers
  • Patent analysts, patent search and information specialists
  • Technology lawyers
  • All those involved with patent filings and prosecution in the United States

Popular with...

This course has proven particularly popular among our customers in these roles:

  • European Patent Attorney
  • IP Analyst
  • IP Manager
  • Manager
  • Patent Attorney
  • Patent Engineer
  • Patent Manager
  • Patent counsel
  • Secretary
  • Senior Patent Attorney

Enrol/reserve

This course will cover:

Module 1: Foundations of US Patent Practice

Overview of the US patent system

  • Courts, USPTO and PTAB
  • Key differences between US and European practice
  • Patentability requirements
  • Recent legislative and judicial developments

Claim construction and drafting for success

  • Claim interpretation in US courts
  • USPTO claim examination standards
  • Drafting claims for prosecution and enforcement
  • Common drafting pitfalls

Module 2: Patentability and prosecution strategy

Written description and enablement

  • Current Federal Circuit guidance
  • Possession requirement
  • Enablement after Amgen
  • Practical drafting strategies

Subject matter eligibility

  • Alice and its continuing impact
  • Software and AI inventions
  • USPTO guidance updates
  • Emerging trends 

Novelty and prior art

  • First-to-file framework
  • Prior art considerations
  • Grace periods
  • Inventor disclosures

Module 3: Building stronger US patent portfolios

Obviousness

  • Current obviousness standards
  • KSR and subsequent developments
  • Drafting and prosecution strategies

Functional claiming

Method claims

  • Impossibility
  • Judicial interpretation

Strategic filing approaches

  • Provisional applications
  • Continuations
  • Continuations-in-part
  • Divisionals
  • Global filing considerations

Restriction practice

  • Restriction requirements
  • Election of species
  • Rejoinder practice

Module 4: PTAB, enforcement and emerging issues

Post grant challenges

  • Inter Partes Review (IPR)
  • Post-Grant Review (PGR)
  • Reissue and re-examination
  • Current PTAB trends

Patent term and portfolio management

  • Patent term adjustment
  • Patent term extension
  • Terminal disclaimers
  • Recent developments

Inventorship and ownership

  • Joint inventorship
  • AI-assisted inventions
  • Ownership disputes
  • Assignment issues

Enforcement and litigation

  • Direct and indirect infringement
  • Doctrine of equivalents
  • Willfulness
  • Damages and remedies
  • Licensing considerations

Future trends

  • AI and patent practice
  • Emerging USPTO initiatives
  • Key cases to watch
  • International developments impacting US practice

Enrol/reserve

James Suggs
McDonnell Boehnen Hulbert & Berghoff LLP

James V. Suggs is a partner in the intellectual property law firm McDonnell Boehnen Hulbert & Berghoff LLP, located in Chicago, where he practices patent law and serves as Chair of the firm’s Chemical Practice Group. He applies his broad technical experience in a wide variety of chemical, polymer, materials science, pharmaceutical, optical, photonic, semiconductor and related technologies. He handles all facets of patent law, with an especial focus in patent procurement, strategic counseling, freedom-to-operate and due diligence opinions.

He also has an active inter partes review practice. His litigation experience includes federal district court and appellate practice as well as advocacy in forums such as the International Trade Commission, and spans a diverse range of technologies. He has experience with all kinds of clients, from large multinational corporations, to science-based startups, to academic research institutions, and works with law firms in Europe and worldwide to successfully prosecute their applications at the USPTO.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate
  • 40% off the 3rd delegate
  • 50% off the 4th delegate

Please contact us for pricing if you are interested in booking 5 or more delegates

3-6 November 2026

Live online

13:30-17:00 UK (London) (UTC+00)
14:30-18:00 Paris (UTC+01)
08:30-12:00 New York (UTC-05)
Course code 16394

  • GBP 1,199 1,399
  • EUR 1,679 1,959
  • USD 1,927 2,239

Until 29 Sep

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's Mastering US Patent Practice: Prosecution, Strategy and Recent Developments training course


Great course materials with plenty of detail which I can use in the future.

Jun 13 2024

Sarah James
Patent Attorney, Unilever

Dec 15 2022

The content, the presentation and the speaker were very good. All topics were presented in a clear manner.

MARIA LUISA MARCHESI
Italian Patent Attorney, ENI CORPORATE UNIVERSITY SPA

Dec 5 2019

Excellent! Very good and helpful overview of US patent law with a focus on the differences to European law. I particularly liked the very interactive discussions.

Hendrik Freudenberger
IP Legal Advisor, Sasol Chemie GmbH & Co. KG

Dec 5 2019

Very thorough and well presented.

Elisabetta Mauri
Director of Intellectual Property, Dompé Farmaceutici SPA

Dec 5 2019

The course gives European practitioners a good overview of the peculiarities of US patent law and the ways in which US practice sometimes differs from our own. The presentation was lively and the speakers provided plenty of background from their own experience.

Erik Bartelds
patent attorney, Arnold + Siedsma

Dec 4 2018

Excellent speakers.

Omar Jabarti
Engineer, Saudi Aramco

Jun 13 2018

A great overview, excellent speakers with comprehensive knowledge.

Peter Atzmüller
Key Patent Information Professional, voestalpine Stahl GmbH

Jun 13 2018

The course was exactly what I expected with a good quality of written documentation and highlighting of specific ongoing topics by the speakers.

Andreas Bazzon
Patent Attorney Candidate, Kaminski Harmann Patentanwälte AG

Jun 13 2018

Both entertaining and educative.

Lorenz Kallenbach
Corporate Patent Counsel, Merck

Jun 13 2018

The dual presentation works well. Interaction with audience very positive. Comprehensive update on US patent practice by knowledgeable speakers in an interactive atmosphere.

Marijke Hogenbirk
Senior Patent Attorney , Shell International B.V.

Jun 13 2018

The speakers were very direct and the course was interactive – I never for a minute lost interest.

Asteria Zitrou
Intellectual Property Supervisor, Pharmathen

Jun 14 2017

The course gave a very good general picture of US patent practice and I really liked all the real-life examples.

Leena Marquis
Patent Engineer, Seppo Laine Oy

Jun 14 2017

The presenter was engaging and open to questions.

Claire Goodier
Director of Intellectual Property, International, The Boots Company plc

Dec 5 2016

The speakers are excellent.

Paul Van Helvert
Manager Intellectual Property, Wageningen UR

Dec 5 2016

Entertaining and interesting programme.

Patrick John Couzens
Patent Attorney, Société des Produits Nestlé S.A.

United Kingdom

  • AA Thornton & Co
  • Albany International Ltd
  • ARM Holdings plc
  • AstraZeneca PLC
  • AstraZeneca R&D Charnwood
  • BOC Limited
  • Boult Wade Tennant
  • BP International Ltd
  • BT Group Legal
  • Cambridge Display Technology Ltd
  • Croda Europe Limited
  • D Young & Co LLP
  • Danfoss
  • David H L Edwards Ltd
  • De La Rue International Ltd
  • Dechert LLP
  • DePuy International Limited
  • Dupont Teijin Films UK Ltd
  • EBS DEALING RESOURCES INT LTD
  • Element Six Ltd
  • Eli Lilly & Co Ltd
  • GE Healthcare UK Ltd
  • Glory Global Solutions
  • Hoffmann Eitle
  • Hoffmann Eitle & Partner
  • Infineum UK Ltd
  • ip21 Limited
  • Kennedys Patent
  • Lifescan Scotland Ltd
  • Mewburn Ellis LLP
  • Nissan Technical Centre Europe
  • Nokia UK Ltd
  • NXP Semicondutors
  • Olswang LLP
  • ORANGE Ltd
  • Oxford Gene Technology IP Ltd
  • Pfizer Limited
  • Procter & Gamble Technical Centres Limited
  • Procter & Gamble Technical Centres Ltd
  • QinetiQ Limited
  • R G C Jenkins & Co
  • Rolls Royce PLC
  • Schlumberger Cambridge Research
  • Sharp Laboratories of Europe Limited
  • Sharp Life Science (EU) Limited
  • Solexa
  • Sony Europe Limited
  • Stratagem IPM Limited
  • Syngenta Limited
  • Teva UK Ltd
  • The Boots Company plc
  • u-blox Melbourn Ltd
  • Unilever
  • Unilever PLC
  • Vectura Group plc
  • Warwick Partnership Ltd
  • Williams Powell
  • Wolfson Microelectronics PLC
  • Xeros Limited

Netherlands

  • AOMB Intellectual Property Consultants
  • Arnold & Siedsma
  • Arnold + Siedsma
  • ASM
  • ASML Netherlands BV
  • Draka Comteq Fibre BV
  • DSM IP & Licensing BV
  • EDP Patent Attorneys B.V.
  • EP&C
  • Exter Polak & Charlouis b.v.
  • Genmab B.V.
  • Helze BV
  • Liquavista BV
  • NLO
  • Nutricia Research BV
  • Octrooibureau Van der Lely N.V.
  • Philips International B.V. - IP&S
  • Shell International B.V.
  • Shell International BV
  • TBG Europe NV
  • TomTom International B.V.
  • Unilever Patent Group
  • Unitpat B.V.
  • V.O.
  • Wageningen UR

Denmark

  • Alk Abello
  • Ambu A/S
  • Awapatent A/S
  • Budde Schou
  • Chas Hude A/S
  • Coloplast A/S
  • Dako Denmark A/S
  • DuPont Nutrition Biosciences ApS
  • Ferring Pharmaceuticals
  • Fertin Pharma A/S
  • Genmab A/S
  • Glycom A/S
  • Hoiberg A/S
  • HØIBERG P/S
  • Leo Pharma A/S
  • Nokia Danmark A/S
  • Novo Nordisk A/S
  • Patentgruppen A/S
  • Santaris Pharma
  • Widex A/S

Germany

  • 7000 andrees Patentanwaltskanzlei
  • ALBIHNS GmbH
  • Bardehle Pagenberg Partnerschaft mbB
  • DEGUSSA AG
  • European Patent Office
  • GPC BIOTECH AG
  • Grunenthal GmbH
  • Hafner and Partner
  • Henkel KGaA
  • OSRAM Opto Semiconductors GmbH
  • Procter & Gamble Service GmbH
  • Sasol Chemie GmbH & Co. KG
  • Umicore AG & Co. KG
  • Volkswagen AG
  • White & Case LLP
  • YARA Digital Farming

Switzerland

  • Actelion Pharmaceutical Ltd
  • Alstom Technology Ltd
  • Bemido SA
  • F. Hoffmann-La Roche AG
  • F. Hoffmann-La Roche Ltd
  • Geistlich Pharma AG
  • INVENTO AG
  • Merck
  • Nestec SA
  • Novartis Pharma AG
  • Procter & Gamble
  • Roche Diagnostics Ltd
  • Schneider Feldmann AG
  • SERONO INTERNATIONAL SA
  • Société des Produits Nestlé S.A.
  • Telix Pharmaceuticals

Sweden

  • AB Electrolux
  • Alfa Laval Corporate AB
  • Aros Patent AB
  • Brann AB
  • Ericsson AB
  • Ericsson AB (EAB)
  • ESAB AB
  • Hansson Thyresson Patentbyra AB
  • Östlund Patent AB
  • Sony Mobile Communications AB
  • Spotify
  • Spotify AB
  • Valea AB
  • Zacco Sweden AB

Italy

  • Alfa Wassermann S.p.A.
  • Barzano&Zanardo Roma spa
  • chiesi farmaceutici
  • Chiesi Farmaceutici SPA
  • Dompé Farmaceutici SPA
  • ENI CORPORATE UNIVERSITY SPA
  • Invatec SRL
  • Pirelli & C SPA
  • Provvisionato & Co S.r.l.
  • Sealed Air S.r.l.
  • Sisvel SpA
  • Solvay Solexis SpA
  • Studio Bonini Srl

Belgium

  • Beloem
  • CNH Industrial Belgium NV
  • De Clercq & Partners
  • ExxonMobil Chemical Europe Inc
  • Fujirebio-Europe NV
  • IMEC vzw
  • Janssen Pharmaceutica NV
  • P&G
  • Sofics BVBA
  • Umicore Research & Development
  • Yara SA/NV

Finland

  • Berggren Oy Ab
  • Kemira OYJ
  • Kolster OY AB
  • Microsoft Mobile Oy
  • Primrose Oy
  • Seppo Laine Oy
  • Tampereen Patenttitoimisto Oy
  • UPM-Kymmene Corporation
  • VTT (Technical Research Centre of Finland)

France

  • Cabinet Barre Laforgue & Associes
  • Cabinet Michel Richebourg
  • Cabinet NONY
  • Chanel PB
  • Medincell
  • SEB Developpement

Spain

  • Corporación Medichem, S.L.
  • J Uriach Y Compania
  • KAO Corporation S.A.
  • Oficini Ponti, S.L.
  • Uriach
  • ZBM Patents S.L.

Austria

  • Borealis Polyolefine GmbH
  • Sandoz GmbH
  • Sonn & Partner
  • Valneva Austria GmbH
  • voestalpine Stahl GmbH

Poland

  • EUPATENT.PL Adam Pawlowski
  • PATPOL
  • Patpol Kancelaria Patentowa sp. z o.o.
  • Patpol Kancelaria Patentowa sp. z.o.o.

Hungary

  • Chinoin Zrt - member of sanofi-aventis Group
  • EGIS Pharmaceuticals PLC
  • Gedeon Richter Plc

Liechtenstein

  • Kaminski Harmann Patentanwalte
  • Kaminski Harmann Patentanwälte AG
  • Kaminski Harmann Patentwalte

Portugal

  • Industrial Property Portuguese Office
  • J E Dias Costa, Lda
  • Raul Cesar Ferreira (Herd) SA

India

  • GE India Technology Centre Pvt Ltd
  • Tata Steel

Norway

  • StatoilHydro ASA
  • Yara International

Saudi Arabia

  • Al-Elm Information Security
  • Saudi Aramco

Singapore

  • China Sinda Intellectual Property Pte Ltd
  • Panasonic Singapore Laboratories

United States of America

  • Microsoft Mobile Oy
  • Scynexis Inc

Canada

  • Novelis Inc

Chile

  • Kura Biotech

Greece

  • Pharmathen

Hong Kong

  • ASTEC CUSTOM POWER (HK) LTD

North Macedonia

  • Alkaloid AD Skopje

Russia

  • Technology Company Schlumberger

Slovenia

  • LEK Pharmaceuticals d.d.

Turkey

  • Sanovel Pharmaceutical INC

Enrol/reserve

Run Mastering US Patent Practice: Prosecution, Strategy and Recent Developments Live online for your team

2 days

Typical duration

Pricing from:

  • GBP 950
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our team to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to our team to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Harry Altamont

Harry
ALTAMONT

Aleksandra Beer

Aleksandra
BEER

+44 (0)20 7749 4749

inhouse@ipiacademy.com